Crossmark

Genetic identification of brain cell types underlying schizophrenia

Crossref DOI link: https://doi.org/10.1038/s41588-018-0129-5

Published Online: 2018-05-21

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Skene, Nathan G.

Bryois, Julien

Bakken, Trygve E.

Breen, Gerome https://orcid.org/0000-0003-2053-1792
Crowley, James J.

Gaspar, Héléna A. https://orcid.org/0000-0002-5540-2707
Giusti-Rodriguez, Paola https://orcid.org/0000-0002-1921-1305
Hodge, Rebecca D.

Miller, Jeremy A.

Muñoz-Manchado, Ana B.

O’Donovan, Michael C. https://orcid.org/0000-0001-7073-2379
Owen, Michael J. https://orcid.org/0000-0003-4798-0862
Pardiñas, Antonio F. https://orcid.org/0000-0001-6845-7590
Ryge, Jesper

Walters, James T. R. https://orcid.org/0000-0002-6980-4053
Linnarsson, Sten https://orcid.org/0000-0002-3491-3444
Lein, Ed S. https://orcid.org/0000-0001-9012-6552
Sullivan, Patrick F.

Hjerling-Leffler, Jens https://orcid.org/0000-0002-4539-1776
License Information

Text and Data Mining valid from 2018-05-21
More Information

Article History

Received: 8 June 2017

Accepted: 3 April 2018

First Online: 21 May 2018

Competing interests

: P.F.S. is on the advisory committee at Lundbeck, is a Scientific Advisory Board member at Pfizer and has received speaker reimbursement and grant funding from Roche. J.H.-L. is a Scientific Advisor at Cartana and has received grant funding from Roche.